Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 2,963 | 2,844 | 2,132 | 3,833 | 3,062 |
| Gross Profit | 2,963 | 2,844 | 2,132 | 3,910 | 3,060 |
| Operating Expenses | 6,614 | 5,915 | 5,126 | 9,900 | 4,830 |
| Operating Income | -3,651 | -3,071 | -2,994 | -6,067 | -1,768 |
| Other Income | -2,254 | 57 | 448 | 44,177 | -1,682 |
| Pre-tax Income | -5,905 | -3,014 | -2,546 | 38,110 | -3,450 |
| Net Income Continuous | -5,905 | -3,014 | -2,546 | 37,641 | -3,451 |
| Net Income | $-5,905 | $-3,014 | $-2,546 | $37,641 | $-3,451 |
| EPS Basic Total Ops | -0.41 | -0.21 | -0.18 | 2.67 | -0.25 |
| EPS Basic Continuous Ops | -0.41 | -0.21 | -0.18 | 2.67 | -0.25 |
| EPS Diluted Total Ops | -0.41 | -0.21 | -0.18 | 2.47 | -0.25 |
| EPS Diluted Continuous Ops | -0.41 | -0.21 | -0.18 | 2.47 | -0.25 |
| EBITDA(a) | $-3,503 | $-2,919 | $-2,828 | $-5,887 | $-1,548 |